Testing the Addition of a New Immunotherapy Drug, Atezolizumab (MPDL3280A), to the Usual Chemoradiation (CRT) Therapy Treatment for Limited Stage Small Cell Lung Cancer (LS-SCLC)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University of Washington
City of Hope Medical Center
University of Texas Southwestern Medical Center
Menoufia University
Laibin People's Hospital
RTOG Foundation, Inc.
Shanghai Chest Hospital
NYU Langone Health
University of Kentucky
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center